Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Infections at risk for epidemic or biological threat. Importance of the initial management of suspect patients].
Leport C, Vittecoq D, Perronne C, Debord T, Carli P, Camphin P, Bricaire F; Comité de pilotage de la coordination des urgences infectieuses et du risque épidémique et biologique (CO REB) en île-de-France. Leport C, et al. Presse Med. 2011 Apr;40(4 Pt 1):336-40. doi: 10.1016/j.lpm.2010.10.033. Epub 2011 Jan 21. Presse Med. 2011. PMID: 21256694 Free PMC article. No abstract available.
[Bioterrorism].
Bricaire F, Coignard-Biehler H, Leport C. Bricaire F, et al. Among authors: leport c. Rev Prat. 2017 Jan;67(1):e8. Rev Prat. 2017. PMID: 30512455 French. No abstract available.
Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?
Laurichesse JJ, Taieb A, Capoulade-Metay C, Katlama C, Villes V, Drobacheff-Thiebaud MC, Raffi F, Chêne G, Theodorou I, Leport C; ANRS C08 Aproco-Copilote Study Group. Laurichesse JJ, et al. Among authors: leport c. HIV Med. 2010 Apr;11(4):239-44. doi: 10.1111/j.1468-1293.2009.00769.x. Epub 2009 Dec 28. HIV Med. 2010. PMID: 20050936 Free PMC article.
Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.
Savès M, Raffi F, Capeau J, Rozenbaum W, Ragnaud JM, Perronne C, Basdevant A, Leport C, Chêne G; Antiprotéases Cohorte (APROCO) Study Group. Savès M, et al. Among authors: leport c. Clin Infect Dis. 2002 May 15;34(10):1396-405. doi: 10.1086/339866. Epub 2002 Apr 22. Clin Infect Dis. 2002. PMID: 11981737
422 results